Author Question: Which of the following mechanisms probably contribute to the beneficial effects of continuous ... (Read 56 times)

go.lag

  • Hero Member
  • *****
  • Posts: 667
Which of the following mechanisms probably contribute to the beneficial effects of continuous positive airway pressure (CPAP) in treating atelectasis?
 
  1. Recruitment of collapsed alveoli
  2. Decreased work of breathing
  3. Improved distribution of ventilation
  4. Increased efficiency of secretion removal
  a. 1, 2, and 4 only
  b. 2 and 3 only
  c. 1 and 4 only
  d. 1, 2, 3, and 4

Question 2

Which of the following are contraindications for continuous positive airway pressure (CPAP) therapy? 1. Hemodynamic instability 2. Hypoventilation 3. Facial trauma 4. Low intracranial pressures
 
  a. 1 and 3 only
  b. 2 and 3 only
  c. 1, 2, and 3 only
  d. 2, 3, and 4 only



Cnarkel

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: D
Exactly how CPAP helps resolve atelectasis is unknown. However, the following factors proba-bly contribute to its beneficial effects: (1) the recruitment of collapsed alveoli via an increase in FRC, (2) a decreased work of breathing due to increased compliance or elimination of au-to-positive end expiratory pressure (PEEP), (3) an improved distribution of ventilation through collateral channels (e.g., Kohn pores), and (4) an increase in the efficiency of secretion removal.

Answer to Question 2

ANS: C
The patient who is hemodynamically unstable is not likely to tolerate CPAP for even a short pe-riod of time. The patient who is suspected of having hypoventilation is not a good candidate for CPAP because it does not ensure ventilation. Other problems that may indicate that CPAP is not an appropriate therapy include nausea, facial trauma, untreated pneumothorax, and elevated in-tracranial pressure.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

For a complete list of videos, visit our video library